VOR BIOPHARMA INC (VOR)
US9290331084 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to VOR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.98. This target is 760.99% above the current price.
VOR was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about VOR.
In the previous month the buy percentage consensus was at a similar level.
VOR was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-21 | Stifel | Maintains | Buy -> Buy |
| 2024-03-21 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-18 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-11 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-16 | JonesTrading | Initiate | Buy |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-03-24 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-24 | Oppenheimer | Reiterate | Outperform |
| 2023-03-24 | Stifel | Maintains | Buy |
| 2023-03-24 | Truist Securities | Maintains | Buy |
| 2023-03-24 | Baird | Maintains | Outperform |
| 2023-03-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-13 | JMP Securities | Reiterate | Market Outperform |
| 2023-01-19 | JMP Securities | Maintains | Market Outperform |
| 2022-11-14 | Oppenheimer | Maintains | Outperform |
| 2022-11-11 | Barclays | Maintains | Overweight |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-07-26 | Wedbush | Initiate | Outperform |
| 2022-05-24 | Goldman Sachs | Maintains | Neutral |
| 2022-05-13 | JMP Securities | Maintains | Market Outperform |
| 2022-04-27 | Goldman Sachs | Initiate | Neutral |